Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-25T12:34:34.214Z Has data issue: false hasContentIssue false

8 - Human T-lymphotropic virus type 1 and disease in the central nervous system

from Section II - Introduction: retroviruses, DNA viruses, and prions

Published online by Cambridge University Press:  22 August 2009

Angelina J. Mosley
Affiliation:
Department of Neuroinflammation, Institute of Neurology, University College London, London, UK
Charles R.M. Bangham
Affiliation:
Department of Immunology, Wright-Fleming Institute, Imperial College, Norfolk Place, London, UK
Carol Shoshkes Reiss
Affiliation:
New York University
Get access

Summary

Introduction

The exogenous human retrovirus human T-lymphotropic virus type 1 (HTLV-1) results in a highly dynamic persistent infection that has a significant clinical impact in endemic areas. HTLV-1 usually causes an asymptomatic infection, but in a small proportion of individuals disease may develop: adult T-cell leukemia or a range of inflammatory diseases. Of these inflammatory diseases HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the most studied. HAM/TSP is a chronic inflammatory disease of the central nervous system. It is rarely fatal, but can be severely debilitating. HTLV-1 is not a classical neurotropic virus and does not directly infect the cells of the central nervous system (CNS). Instead, HTLV-1 is found primarily within infiltrating, infected CD4+ T lymphocytes. CD4+ T-cell infiltration into the CNS is currently believed to be the pivotal event for the pathogenesis of HAM/TSP. Here we describe the immune control of HTLV-1 infection in the periphery and discuss its relationship with inflammation in the CNS. We explore the current hypothesis of HAM/TSP pathogenesis, identify crucial factors, and suggest a new hypothesis focused on why the majority of HTLV-1-infected individuals do not develop neuroinflammatory disease.

HTLV-1

HTLV-1 was the first exogenous replication competent human retrovirus to be identified over 20 years ago by Poiesz et al. [1]. HTLV-1 virions were isolated from a cell line established from a cutaneous T-cell lymphoma. HTLV-1 has since been associated with two different types of disease: lymphoma/leukemia and chronic inflammatory diseases [2, 3, 4, 5].

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Poiesz, B. J., Ruscetti, F. W., Gazdar, A.F., et al., Proc Natl Acad Sci USA, 77 (1980) 7415–19.CrossRef
Bangham, C.R.M., J Clin Pathol, 53 (2000) 581–6.CrossRef
Cann, A.J. and Chen, I.S.Y., Human T-cell leukemia virus types I and II. In Fields, B.N., Knipe, D.M., Howley, P.M. (Eds.), Fields virology, Lippincott-Raven, Philadelphia, 1996, pp.1849–68.Google Scholar
Mueller, N.E. and Blattner, W.A. In Evans, A.S., Kaslow, R.A. (Eds.), Viral infections of humans, Plenum Medical Book Company, New York and London, 1997, pp.785–813.CrossRefGoogle Scholar
Uchiyama, T., Annu Rev Immunol, 15 (1997) 15–37.CrossRef
The, G. and Bomford, R., AIDS Res Hum Retroviruses, 9 (1993) 381–6.CrossRef
Slattery, J.P., Franchini, G., and Gessain, A., Genome Res, 9 (1999) 525–40.
Touze, E., Gessain, A., Lyon-Caen, O., et al., J Acquir Immune Defic Syndr Hum Retrovirol, 13 (Suppl 1) (1996) S38–45.CrossRef
Goon, P.K. and Bangham, C.R., Clin Exp Immunol, 137 (2004) 234–6.CrossRef
Murai, K., Tachibana, N., Shioiri, S., et al., J Acquir Immune Defic Syndr, 3 (1990) 1006–9.
Suzuki, M., Dezzutti, C.S., Okayama, A., et al., Clin Diagn Lab Immunol, 6 (1999) 713–17.
Tachibana, N., Okayama, A., Ishizaki, J., et al., Int J Cancer, 42 (1988) 829–31.CrossRef
Welles, S.L., Tachibana, N., Okayama, A., et al., Int J Cancer, 56 (1994) 337–40.CrossRef
Albrecht, B. and Lairmore, M.D., Microbiol Mol Biol Rev, 66 (2002) 396–406, table of contents.CrossRef
Arnold, J., Yamamoto, B., Li, M., et al., Blood, 107 (2006) 3976–82.CrossRef
Cavanagh, M.H., Landry, S., Audet, B., et al., Retrovirology, 3 (2006) 15.CrossRef
Satou, Y., Yasunaga, J., Yoshida, M., et al., Proc Natl Acad Sci USA, 103 (2006) 720–5.CrossRef
Marriott, S.J., Boros, I., Duvall, J.F., et al., Mol Cell Biol, 9 (1989) 4152–60.CrossRef
Armstrong, A.P., Franklin, A.A., Uittenbogaard, M.N., et al., Proc Natl Acad Sci USA, 90 (1993) 7303–7.CrossRef
Seeler, J.S., Muchardt, C., Podar, M., et al., Virology, 196 (1993) 442–50.CrossRef
Bex, F. and Gaynor, R.B., Methods, 16 (1998) 83–94.CrossRef
Mesnard, J.M. and Devaux, C., Virology, 257 (1999) 277–84.CrossRef
Hanon, E., Hall, S., Taylor, G.P., et al., Blood, 95 (2000) 1386–92.
Richardson, J.H., Edwards, A.J., Cruikshank, J.K., et al., J Virol, 64 (1990) 5682–7.
Hanon, E., Stinchcombe, J.C., Saito, M., et al., Immunity, 13 (2000) 657–64.CrossRef
Cho, I., Sugimoto, M., Mita, S., et al., Am J Trop Med Hyg, 53 (1995) 412–18.CrossRef
Coscoy, L., Gonzalez-Dunia, D., Brahic, M., et al., J Gen Virol, 78 (Pt 1) (1997) 143–6.CrossRef
Ho, D.D., Rota, T.R., and Hirsch, M.S., Proc Natl Acad Sci USA, 81 (1984) 7588–90.CrossRef
Hoffman, P.M., Dhib-Jalbut, S., Mikovits, J.A., et al., Proc Natl Acad Sci USA, 89 (1992) 11784–8.CrossRef
Hoxie, J.A., Matthews, D.M., and Cines, D.B., Proc Natl Acad Sci USA, 81 (1984) 7591–5.CrossRef
Koyanagi, Y., Itoyama, Y., Nakamura, N., et al., Virology, 196 (1993) 25–33.CrossRef
Igakura, T., Stinchcombe, J.C., Goon, P.K., et al., Science, 299 (2003) 1713–16.CrossRef
Derse, D., Mikovits, J., Polianova, M., et al., J Virol, 69 (1995) 1907–12.
Trentin, B., Rebeyrotte, N., and Mamoun, R.Z., J Virol, 72 (1998) 6504–10.
Taylor, G.P., Hall, S.E., Navarrete, S., et al., J Virol, 73 (1999) 10289–95.
Cavrois, M., Gessain, A., Wain-Hobson, S., et al., Oncogene, 12 (1996) 2419–23.
Cavrois, M., Leclercq, I., Gout, O., et al., Oncogene, 17 (1998) 77–82.CrossRef
Okayama, A., Tachibana, N., Ishihara, S., et al., J Acquir Immune Defic Syndr Hum Retrovirol, 15 (1997) 70–5.CrossRef
Kim, S.J., Nair, A.M., Fernandez, S., et al., J Immunol, 176 (2006) 5463–70.CrossRef
Wattel, E., Vartanian, J.P., Pannetier, C., et al., J Virol, 69 (1995) 2863–8.
Nagai, M., Usuku, K., Matsumoto, W., et al., J Neurovirol, 4 (1998) 586–93.CrossRef
Asquith, B., Hanon, E., Taylor, G.P., et al., Philos Trans R Soc Lond B Biol Sci, 355 (2000) 1013–19.CrossRef
Furukawa, Y., Osame, M., Kubota, R., et al., Blood, 85 (1995) 1865–70.
Kinoshita, T., Shimoyama, M., Tobinai, K., et al., Proc Natl Acad Sci USA, 86 (1989) 5620–4.CrossRef
Moritoyo, T., Izumo, S., Moritoyo, H., et al., J Neurovirol, 5 (1999) 241–8.CrossRef
Asquith, B., Zhang, Y., Mosley, A., et al., PNAS (2006) submitted.
Gessain, A., Barin, F., Vernant, J.C., et al., Lancet, 2 (1985) 407–10.CrossRef
Osame, M., Usuku, K., Izumo, S., et al., Lancet, 1 (1986) 1031–2.CrossRef
Hollsberg, P. and Hafler, D.A., N Engl J Med, 328 (1993) 1173–82.
Imamura, A., Kitagawa, T., Ohi, Y., et al., Urol Int, 46 (1991) 149–53.CrossRef
Kiwaki, T., Umehara, F., Arimura, Y., et al., J Neurol Sci, 206 (2003) 17–21.CrossRef
Leite, A.C., Silva, M.T., Alamy, A.H., et al., J Neurol, 251 (2004) 877–81.CrossRef
Nakagawa, M., Izumo, S., Ijichi, S., et al., J Neurovirol, 1 (1995) 50–61.CrossRef
Matsuzaki, T., Nakagawa, M., Nagai, M., et al., J Neurovirol, 7 (2001) 228–34.
Takenouchi, N., Yamano, Y., Usuku, K., et al., J Neurovirol, 9 (2003) 29–35.CrossRef
Izumo, S., Ijichi, T., Higuchi, I., et al., Acta Paediatr Jpn, 34 (1992) 358–64.CrossRef
Iwasaki, Y., J Neurol Sci, 96 (1990) 103–23.CrossRef
Sasaki, S., Komori, T., Maruyama, S., et al., Acta Neuropathol, 81 (1990) 219–22.CrossRef
Osame, M., J Neurovirol, 8 (2002) 359–64.CrossRef
Aye, M.M., Matsuoka, E., Moritoyo, T., et al., Acta Neuropathol, 100 (2000) 245–52.CrossRef
Iwasaki, Y., Brain Pathology (Zurich, Switzerland), 3 (1993) 1–10.CrossRef
Iwasaki, Y., Ohara, Y., Kobayashi, I., et al., Am J Pathol, 140 (1992) 1003–8.
Umehara, F., Izumo, S., Nakagawa, M., et al., J Neuropathol Exp Neurol, 52 (1993) 424–30.CrossRef
Umehara, F., Nakamura, A., Izumo, S., et al., J Neuropathol Exp Neurol, 53 (1994) 617–24.CrossRef
Bagnato, F., Butman, J.A., Mora, C.A., et al., J Neurovirol, 11 (2005) 525–34.CrossRef
Jacobson, S., Raine, C.S., Mingioli, E.S., et al., Nature, 331 (1988) 540–3.CrossRef
Hara, Y., Takahashi, M., Ueno, S., et al., J Comput Assist Tomogr, 12 (1988) 750–4.CrossRef
Kira, J., Minato, S., Itoyama, Y., et al., J Neurol Sci, 87 (1988) 221–32.CrossRef
Melo, A., Moura, L., Rios, S., et al., Arq Neuropsiquiatr, 51 (1993) 329–32.CrossRef
Kira, J., Fujihara, K., Itoyama, Y., et al., J Neurol Sci, 106 (1991) 41–9.CrossRef
Kaplan, J.E., Osame, M., Kubota, H., et al., J Acquir Immune Defic Syndr, 3 (1990) 1096–101.
Bangham, C.R., Hall, S.E., Jeffery, K.J., et al., Philos Trans R Soc Lond B Biol Sci, 354 (1999) 691–700.CrossRef
Goon, P.K., Biancardi, A., Fast, N., et al., J Infect Dis, 189 (2004) 2294–8.CrossRef
Jeffery, K.J., Usuku, K., Hall, S.E., et al., Proc Natl Acad Sci USA, 96 (1999) 3848–53.CrossRef
Parker, C.E., Daenke, S., Nightingale, S., et al., Virology, 188 (1992) 628–36.CrossRef
Asquith, B., Mosley, A.J., Heaps, A., et al., Retrovirology, 2 (2005) 75.CrossRef
Daenke, S., Nightingale, S., Cruickshank, J.K., et al., J Virol, 64 (1990) 1278–82.
Evangelista, A., Maroushek, S., Minnigan, H., et al., Microb Pathog, 8 (1990) 259–78.CrossRef
Nishimura, M., McFarlin, D.E., and Jacobson, S., Neurology, 43 (1993) 2621–4.CrossRef
Sambor, A.M., Oliveira, Pombo M.S., Farhadi, A., et al., J Hum Virol, 2 (1999) 308–14.
Furukawa, Y., Yamashita, M., Usuku, K., et al., J Infect Dis, 182 (2000) 1343–9.CrossRef
Vine, A.M., Witkover, A.D., Lloyd, A.L., et al., J Inf Dis, 186 (2002) 932–9.CrossRef
Jeffery, K.J., Siddiqui, A.A., Bunce, M., et al., J Immunol, 165 (2000) 7278–84.CrossRef
Kasai, T., Ikeda, H., Tomaru, U., et al., Acta Neuropathol, 97 (1999) 107–12.CrossRef
Ohshio, I., Hatayama, A., Kaneda, K., et al., Spine, 18 (1993) 1140–9.CrossRef
Ohya, O., Ikeda, H., Tomaru, U., et al., APMIS, 108 (2000) 459–66.CrossRef
Ohya, O., Tomaru, U., Yamashita, I., et al., Leukemia, 11 (Suppl 3) (1997) 255–7.
Kazanji, M., AIDS Res Hum Retroviruses, 16 (2000) 1741–6.CrossRef
Kazanji, M., Ureta-Vidal, A., Ozden, S., et al., J Virol, 74 (2000) 4860–7.CrossRef
Pique, C., Connan, F., Levilain, J.P., J Virol, 70 (1996) 4919–26.
Pique, C., Ureta-Vidal, A., Gessain, A., et al., J Exp Med, 191 (2000) 567–72.CrossRef
Biddison, W.E., Kubota, R., Kawanashi, T., et al., J Immunol, 159 (1997) 2018–25.
Jacobson, S., Shida, H., McFarlin, D.E., et al., Nature, 348 (1990) 245–8.CrossRef
Asquith, B. and Bangham, C.R.M., J Theor Biol, 207 (2000) 65–79.CrossRef
Bangham, C.R.M., Kermode, A.G., Hall, S.E., et al., Seminars in Virology, 7 (1996) 41–8.CrossRef
Asquith, B., Mosley, A.J., Barfield, A., et al., J Gen Virol, 86 (2005) 1515–23.CrossRef
Rafatpanah, H., Pravica, V., Farid, R., et al., Hum Immunol, 65 (2004) 839–46.CrossRef
Sabouri, A.H., Saito, M., Usuku, K., et al., J Gen Virol, 86 (2005) 773–81.CrossRef
Niewiesk, S., Daenke, S., Parker, C.E., et al., J Virol, 68 (1994) 6778–81.
Vine, A.M., Heaps, A.G., Kaftantzi, L., et al., J Immunol, 173 (2004) 5121–9.CrossRef
Feinberg, M.B. and McLean, A.R., Curr Biol, 7 (1997) R136–140.CrossRef
Rickinson, A.B. and Moss, D.J., Annu Rev Immunol, 15 (1997) 405–31.CrossRef
Rook, A.H., Rev Infect Dis, 10 (Suppl 3) (1988) S460–7.CrossRef
Kubota, R., Kawanishi, T., Matsubara, H., et al., J Immunol, 161 (1998) 482–8.
Elovaara, I., Koenig, S., Brewah, A.Y., et al., J Exp Med, 177 (1993) 1567–73.CrossRef
Daenke, S., Kermode, A.G., Hall, S.E., et al., Virology, 217 (1996) 139–46.CrossRef
Parker, C.E., Nightingale, S., Taylor, G.P., et al., J Virol, 68 (1994) 2860–8.
Kubota, R., Kawanishi, T., Matsubara, H., et al., J Neuroimmunol, 102 (2000) 208–15.CrossRef
Wodarz, D., Hall, S.E., Usuku, K., et al., Proc Biol Sci, 268 (2001) 1215–21.CrossRef
Nagai, M., Kubota, R., Greten, T.F., et al., J Infect Dis, 183 (2001) 197–205.CrossRef
Addo, M.M., Yu, X.G., Rathod, A., et al., J Virol, 77 (2003) 2081–92.CrossRef
Betts, M.R., Ambrozak, D.R., Douek, D.C., et al., J Virol, 75 (2001) 11983–91.CrossRef
Migueles, S.A. and Connors, M., Immunol Lett, 79 (2001) 141–50.CrossRef
Nowak, M.A. and Bangham, C.R., Science, 272 (1996) 74–9.CrossRef
Gessain, A., J Neurovirol, 2 (1996) 299–306.CrossRef
Matsui, M., Nagumo, F., Tadano, J., et al., J Neurol Sci, 130 (1995) 183–9.CrossRef
Kubota, R., Soldan, S.S., Martin, R., et al., J Neurovirol, 8 (2002) 53–7.CrossRef
Jacobson, S., McFarlin, D.E., Robinson, S., et al., Ann Neurol, 32 (1992) 651–7.CrossRef
Brito-Melo, G.E., Martins-Filho, O.A., Carneiro-Proietti, A.B., et al., Scand J Immunol, 55 (2002) 621–8.CrossRef
Kubota, R., Nagai, M., Kawanishi, T., et al., AIDS Res Hum Retroviruses, 16 (2000) 1705–39.CrossRef
Furuya, T., Nakamura, T., Fujimoto, T., et al., J Neuroimmunol, 95 (1999) 185–9.CrossRef
Lezin, A., Buart, S., Smadja, D., et al., AIDS Res Hum Retroviruses, 16 (2000) 965–72.CrossRef
Viviani, B., Bartesaghi, S., Corsini, E., et al., Toxicol Lett, 149 (2004) 85–9.CrossRef
Dufay, N., Reboul, A., Touraine-Moulin, F., et al., J Neurooncol, 43 (1999) 115–26.CrossRef
Hanisch, U.K., Glia, 40 (2002) 140–55.CrossRef
Stoll, G., Jander, S., and Schroeter, M., J Neural Transm, 59 (2000) 81–9.
Sriram, K., Matheson, J.M., Benkovic, S.A., et al., Faseb J, 20 (2006) 670–82.CrossRef
Takeuchi, H., Jin, S., Wang, J., et al., J Biol Chem, 281 (2006) 21362–8.CrossRef
Hanisch, U.K. and Quirion, R., et al., Brain Res, 21 (1995) 246–84.CrossRef
Hanisch, U.K., Lyons, S.A., Prinz, M., et al., J Biol Chem, 272 (1997) 28853–60.CrossRef
Almeida, A., Cidad, P., Delgado-Esteban, M., et al., J Neurosci Res, 79 (2005) 166–71.CrossRef
Togo, T., Katsuse, O., and Iseki, E., Neurol Res, 26 (2004) 563–6.CrossRef
Valitutti, S., Muller, S., Dessing, M., et al., J Exp Med, 183 (1996) 1917–21.CrossRef
Regner, M., Lobigs, M., Blanden, R.V., et al., Scand J Immunol, 54 (2001) 366–74.CrossRef
Kira, J., Nakamura, M., Sawada, T., et al., J Neurol Sci, 107 (1992) 98–104.CrossRef
Manns, A., Miley, W.J., Wilks, R.J., et al., J Infect Dis, 180 (1999) 1487–93.CrossRef
Goon, P.K., Igakura, T., Hanon, E., et al., J Immunol, 172 (2004) 1735–43.CrossRef
Sonoda, S., Fujiyoshi, T., and Yashiki, S., J Acquir Immune Defic Syndr Hum Retrovirol, 13 (Suppl 1) (1996) S119–23.CrossRef
Usuku, K., Nishizawa, M., Matsuki, K., et al., Eur J Immunol, 20 (1990) 1603–6.CrossRef
Goon, P.K., Igakura, T., Hanon, E., et al., J Virol, 77 (2003) 9716–22.CrossRef
Hanon, E., Goon, P., Taylor, G.P., et al., Blood, 98 (2001) 721–6.CrossRefPubMed
Chung, H.K., Young, H.A., Goon, P.K., et al., Blood, 102 (2003) 4130–6.CrossRef
Azimi, N., Shiramizu, K.M., Tagaya, Y., et al., J Virol, 74 (2000) 7338–48.CrossRef
Surh, C.D., Boyman, O., Purton, J.F., et al., Immunol Rev, 211 (2006) 154–63.CrossRef
Azimi, N., Jacobson, S., Leist, T., et al., J Immunol, 163 (1999) 4064–72.
Azimi, N., Mariner, J., Jacobson, S., et al., AIDS Res Hum Retroviruses, 16 (2000) 1717–22.CrossRef
Nishimura, M., Matsuoka, M., Maeda, M., et al., Hum Immunol, 63 (2002) 696–700.CrossRef
Mori, N. and Prager, D., Leuk Lymphoma, 26 (1997) 421–33.CrossRef
Rott, O., Tontsch, U., Fleischer, B., et al., Eur J Immunol, 23 (1993) 1987–91.CrossRef
Santambrogio, L., Benedetti, M., Chao, M.V., et al., J Immunol, 153 (1994) 4488–95.
Kerschensteiner, M., Stadelmann, C., Dechant, G., et al., Ann Neurol, 53 (2003) 292–304.CrossRef
Kerschensteiner, M., Gallmeier, E., Behrens, L., et al., J Exp Med, 189 (1999) 865–70.CrossRef
Bradl, M. and Flugel, A., Curr Top Microbiol Immunol, 265 (2002) 141–62.
Albrecht, D., Garcia, L., Cartier, L., et al., AIDS Res Hum Retroviruses, 22 (2006) 248–54.CrossRef
Yamano, Y., Nagai, M., Brennan, M., et al., Blood, 99 (2002) 88–94.CrossRef
Moritoyo, T., Reinhart, T.A., Moritoyo, H., et al., Ann Neurol, 40 (1996) 84–90.CrossRef
Levin, M.C., Krichavsky, M., Berk, J., et al., Ann Neurol, 44 (1998) 87–98.CrossRef
Levin, M.C., Lee, S.M., Kalume, F., et al., Nat Med, 8 (2002) 509–13.CrossRef
Jernigan, M., Morcos, Y., Lee, S.M., et al., Neurology, 60 (2003) 1320–7.CrossRef
Wucherpfennig, K.W., Nat Med, 8 (2002) 455–7.CrossRef
Garcia-Vallejo, F., Dominguez, M.C., and Tamayo, O., Braz J Med Biol Res, 38 (2005) 241–50.CrossRef
McGonagle, D. and McDermott, M.F., PLoS Med, 3 (2006) e297.CrossRef
Barnard, A.L., Igakura, T., Tanaka, Y., et al., Blood, 106 (2005) 988–95.CrossRef
Giraudon, P., Buart, S., Bernard, A., et al., Prog Neurobiol, 49 (1996) 169–84.CrossRef
Lehky, T.J., Fox, C.H., Koenig, S., et al., Ann Neurol, 37 (1995) 167–75.CrossRef
Akaoka, H., Szymocha, R., Beurton-Marduel, P., et al., Virus Res, 78 (2001) 57–66.CrossRef
Szymocha, R., Akaoka, H., Brisson, C., et al., AIDS Res Hum Retroviruses, 16 (2000) 1723–29.CrossRef
Szymocha, R., Akaoka, H., Dutuit, M., et al., J Virol, 74 (2000) 6433–41.CrossRef
Szymocha, R., Brisson, C., Bernard, A., et al., J Neurovirol, 6 (2000) 350–57.CrossRef
Hickey, W.F., Glia, 36 (2001) 118–24.CrossRef
Hickey, W.F., Hsu, B.L. and Kimura, H., J Neurosci Res, 28 (1991) 254–60.CrossRef
Kniesel, U. and Wolburg, H., Cell Mol Neurobiol, 20 (2000) 57–76.CrossRef
Abbott, N.J., J Anat, 200 (2002) 629–38.CrossRef
Phillips, L.M. and Lampson, L.A., J Neuroimmunol, 96 (1999) 218–27.CrossRef
Yeager, M.P., DeLeo, J.A., Hoopes, P.J., et al., Crit Care Med, 28 (2000) 1477–82.CrossRef
Ransohoff, R.M., Kivisakk, P., and Kidd, G., Nat Rev Immunol, 3 (2003) 569–81.CrossRef
Engelhardt, B. and Ransohoff, R.M., Trends Immunol, 26 (2005) 485–95.CrossRef
Hintzen, R.Q., Fiszer, U., Fredrikson, S., et al., J Neuroimmunol, 56 (1995) 99–105.CrossRef
Svenningsson, A., Andersen, O., Edsbagge, M., et al., J Neuroimmunol, 63 (1995) 39–46.CrossRef
Lezin, A., Olindo, S., Oliere, S., et al., J Infect Dis, 191 (2005) 1830–4.CrossRef
Cavrois, M., Gessain, A., Gout, O., et al., J Infect Dis, 182 (2000) 1044–50.CrossRef
Ichinose, K., Nakamura, T., Nishiura, Y., et al., J Neurol Sci, 122 (1994) 204–9.CrossRef
Romero, I.A., Prevost, M.C., Perret, E., et al., J Virol, 74 (2000) 6021–30.CrossRef
Al-Fahim, A., Cabre, P., Kastrukoff, L., et al., Cell Immunol, 198 (1999) 1–10.CrossRef
Ichinose, K., Nakamura, T., Nishiura, Y., et al., Immunobiology, 196 (1996) 485–90.CrossRef
Furuya, T., Nakamura, T., Shirabe, S., et al., Proc Assoc Am Physicians, 109 (1997) 228–36.
Umehara, F., Izumo, S., Takeya, M., et al., Acta Neuropathol, 91 (1996) 343–50.CrossRef
Tanaka, Y., Hayashi, M., Takagi, S., et al., J Virol, 70 (1996) 8508–17.
Tanaka, Y., Fukudome, K., Hayashi, M., et al., Int J Cancer, 60 (1995) 554–61.CrossRef
Valentin, H., Lemasson, I., Hamaia, S., et al., J Virol, 71 (1997) 8522–30.
Nejmeddine, M., Barnard, A.L., Tanaka, Y., et al., J Biol Chem, 280 (2005) 29653–60.CrossRef
Guerreiro, J.B., Santos, S.B., Morgan, D.J., et al., Clin Exp Immunol, 145 (2006) 296–301.CrossRef
Perry, V.H., Brain Behav Immun, 18 (2004) 407–13.CrossRef
Greenwood, J., Etienne-Manneville, S., Adamson, P., et al., Vascul Pharmacol, 38 (2002) 315–22.CrossRef
Ikegami, M., Umehara, F., Ikegami, N., et al., J Neuroimmunol, 127 (2002) 134–8.CrossRef
Umehara, F., Okada, Y., Fujimoto, N., et al., J Neuropathol Exp Neurol, 57 (1998) 839–49.CrossRef
Sellebjerg, F. and Sorensen, T.L., Brain Res Bull, 61 (2003) 347–55.CrossRef
Abraham, M., Shapiro, S., Karni, A., et al., J Neuroimmunol, 163 (2005) 157–64.CrossRef
Giraudon, P., Szymocha, R., Buart, S., et al., J Immunol, 164 (2000) 2718–27.CrossRef
Kodama, D., Saito, M., Matsumoto, W., et al., J Neuroimmunol, 156 (2004) 188–94.CrossRef
Barmak, K., Harhaj, E., Grant, C., et al., Virology, 308 (2003) 1–12.CrossRef
Barmak, K., Harhaj, E.W., and Wigdahl, B., et al., J Neurovirol, 9 (2003) 522–9.CrossRef
Grant, C., Barmak, K., Alefantis, T., et al., J Cell Physiol, 190 (2002) 133–59.CrossRef
Jacobson, S., J Infect Dis, 186 (Suppl 2) (2002) S187–92.CrossRef
Compston, A. and Coles, A., Lancet, 359 (2002) 1221–31.CrossRef
Hauser, S.L. and Oksenberg, J.R., Neuron, 52 (2006) 61–76.CrossRef
Nose, H., Saito, M., Usuku, K., et al., J Neurovirol, 12 (2006) 171–7.CrossRef
Taylor, G.P., Tosswill, J.H., Matutes, E., et al., J Acquir Immune Defic Syndr, 22 (1999) 92–100.CrossRef
Kira, J., Goto, I., Otsuka, M., et al., J Neurol Sci, 115 (1993) 111–16.CrossRef
Okahashi, Y., Kataoka, H., Kawahara, M., et al., Neurology, 65 (2005) 965–6.CrossRef
Mattson, D.H., McFarlin, D.E., Mora, C., et al., Lancet, 2 (1987) 49.CrossRef
Howard, A.K., Li, D.K., and Oger, J., et al., Can J Neurol Sci, 30 (2003) 41–8.CrossRef
Yata, S., Ogawa, T., Sugihara, S., et al., Neuroradiology, 46 (2004) 755–8.CrossRef
Umehara, F., Tokunaga, N., Hokezu, Y., et al., Neurology, 66 (2006) 289.CrossRef
Coffin, J.M., Varmus, H.E., and Hughes, S.H. (Eds.), Retroviruses, Cold Spring Harbor, NY, CSHL Press, 1992.Google Scholar
Matsuoka, M., Oncogene, 22 (2003) 5131–40.CrossRef

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×